Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Enzo Biochem Inc (ENZ)  
$1.12 0.03 (2.75%) as of 4:30 Wed 5/8


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 47,900,000
Market Cap: 53.65(M)
Last Volume: 92,722 Avg Vol: 374,904
52 Week Range: $1.04 - $2.66
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Laboratories & Research

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P SMALLCAP 600

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Enzo Biochem is a diagnostics, clinical lab, and life sciences company. Co.'s operating segments include: Enzo Clinical Lab, which is a clinical reference laboratory providing a range of clinical services to physicians, medical centers, other clinical labs and pharmaceutical companies; Enzo Life Sciences, which manufactures, develops and markets products and tools for clinical research, drug development and bioscience research customers worldwide; Enzo Therapeutics, which is a biopharmaceutical venture that has developed multiple approaches in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases, various of which are derived from the work of Enzo Life Sciences.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 417,900
Total Buy Value $0 $0 $0 $873,769
Total People Bought 0 0 0 5
Total Buy Transactions 0 0 0 14
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 264
  Page 6 of 11  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Bass Herbert B Vice President of Finance   •       –      –    2010-01-29 4 A $0.00 $0 D/D 3,000 165,112     -
   Balezentis Carl W Pres., Enzo Life Sciences   •       –      –    2010-01-29 4 A $0.00 $0 D/D 12,000 35,754     -
   Goldberg David C VP, Corporate Development   •       –      –    2010-01-29 4 A $0.00 $0 D/D 6,000 67,272     -
   Crescenzo Andrew R. Senior VP of Finance   •       –      –    2010-01-29 4 A $0.00 $0 D/D 12,000 36,110     -
   Krenitsky Kevin President, Enzo Clinical Labs   •       –      –    2009-10-15 4 B $7.70 $50,828 D/D 6,600 6,600 2.74     -
   Rabbani Shahram K Treasurer, Secretary   •       •      –    2009-07-01 4 A $0.00 $0 D/D 82,645 1,539,392     -
   Balezentis Carl W Pres., Enzo Life Sciences,Inc.   •       –      –    2009-01-22 4 A $0.00 $0 D/D 10,000 22,696     -
   Goldberg David C VP, Corporate Development   •       –      –    2009-01-22 4 A $0.00 $0 D/D 4,000 110,547     -
   Fischette Christine Pres., Enzo Therapeutics, Inc.   •       –      –    2009-01-22 4 A $0.00 $0 D/D 3,000 11,500     -
   Bass Herbert B Vice President of Finance   •       –      –    2009-01-22 4 A $0.00 $0 D/D 3,000 207,744     -
   Crescenzo Andrew R. Senior VP of Finance   •       –      –    2009-01-22 4 A $0.00 $0 D/D 9,000 21,803     -
   Balezentis Carl W President, Enzo Life Sciences   •       –      –    2008-10-30 4/A S $5.35 $3,103 D/D (580) 4,420     -
   Balezentis Carl W President, Enzo Life Sciences   •       –      –    2008-10-30 4 S $5.35 $3,103 D/D (580) 4,650     -
   Sias John B Director   –       •      –    2008-09-26 4 OE $5.45 $33,125 D/D 6,078 173,087     -
   Goldberg David C VP, Business Development   •       –      –    2008-09-23 4 D $11.26 $33,127 D/D (2,942) 103,605     -
   Goldberg David C VP, Business Development   •       –      –    2008-09-23 4 OE $5.45 $33,125 D/D 6,078 106,547     -
   Kelker Norman E Senior Vice President   •       –      –    2008-09-23 4 D $11.26 $66,243 D/D (5,883) 110,855     -
   Kelker Norman E Senior Vice President   •       –      –    2008-09-23 4 OE $5.45 $66,245 D/D 12,155 116,738     -
   Bass Herbert B Senior Vice President, Finance   •       –      –    2008-09-23 4 D $11.26 $33,127 D/D (2,942) 200,802     -
   Bass Herbert B Senior Vice President, Finance   •       –      –    2008-09-23 4 OE $5.45 $33,125 D/D 6,078 203,744     -
   Rabbani Shahram K Treasurer and Secretary   •       •      –    2008-09-23 4 D $11.26 $331,112 D/D (29,406) 1,799,088     -
   Rabbani Shahram K Treasurer and Secretary   •       •      –    2008-09-23 4 OE $5.45 $331,115 D/D 60,755 1,828,494     -
   Rabbani Elazar Chairman and CEO   •       •      –    2008-09-23 4 D $11.26 $331,112 D/D (29,406) 2,156,339     -
   Rabbani Elazar Chairman and CEO   •       •      –    2008-09-23 4 OE $5.45 $331,115 D/D 60,755 2,185,745     -
   Weiner Barry W President and CFO   •       •      –    2008-09-23 4 D $11.26 $331,112 D/D (29,406) 1,368,963     -
  264 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 6 of 11
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us